Wide Ranks

ENVB

Enveric Biosciences, Inc.

0.3256

Top Statistics
Market Cap 3 M Forward PE -0.2309 Revenue Growth 0.00 %
Current Ratio 8.55 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.0250 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 3 M Total Cash Per Share 0.3930 Total Debt
Total Debt To Equity Current Ratio 8.55 Book Value Per Share 0.7140
All Measures
Short Ratio 31.00 % Message Board Id finmb_650902272 Shares Short Prior Month 198974
Return On Equity -2.06 City Naples Uuid 25d93899-7d3d-3c56-be11-8ed160fe89cc
Previous Close 0.3270 First Trade Date Epoch Utc 1 B Book Value 0.7140
Beta 0.4690 Volume 42584 Price To Book 0.4560
Last Split Date 1 B Fifty Two Week Low 0.3050 Total Cash Per Share 0.3930
Shares Short Previous Month Date 1 B Max Age 86400 Sand P52 Week Change 0.3133
Net Income To Common -10594461 Short Percent Of Float 0.0373 Implied Shares Outstanding 9 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 189540
Average Volume10days 189540 Total Cash 3 M Next Fiscal Year End 1 B
Held Percent Insiders 0.0693 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 0.3270 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.4443 Open 0.3230
Free Cashflow -9040216 State FL Dividend Yield 0.00 %
Return On Assets -0.8050 Time Zone Short Name EST Trailing Eps -2.42
Day Low 0.3223 Address1 4851 Tamiami Trail N Shares Outstanding 9 M
Price Hint 4 Target High Price 0.0000 Website https://www.enveric.com
52 Week Change -0.7797 Average Volume 518850 Forward Eps -1.41
Recommendation Key none Compensation As Of Epoch Date 1 B Quick Ratio 589.10 %
Last Split Factor 1:50 Regular Market Day High 0.3363 Is_sp_500 False
Profit Margins 0.00 % Fifty Two Week High 2.92 Day High 0.3363
Shares Short 330219 Regular Market Open 0.3230 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0370
Operating Cashflow -9979001 Currency USD Time Zone Full Name America/New_York
Market Cap 3 M Is_nasdaq_100 False Zip 34103
Quote Type EQUITY Industry Biotechnology Ex Dividend Date 1 B
Regular Market Day Low 0.3223 Held Percent Institutions 0.0706 Long Name Enveric Biosciences, Inc.
Current Price 0.3256 Address2 Suite 200 Enterprise To Ebitda 0.0250
Financial Currency USD Current Ratio 8.55 Industry Disp Biotechnology
Country United States Float Shares 8 M Two Hundred Day Average 0.6926
Ir Website http://www.spatializer.com/inv_relations/index.asp Enterprise Value -246780 Forward PE -0.2309
Regular Market Volume 42584 Ebitda -9866837 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.

Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health.

The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer.

Enveric Biosciences, Inc. is headquartered in Naples, Florida.